Download PDF
J Knee Surg 2023; 36(05): 524-529
DOI: 10.1055/s-0041-1739199
Original Article

Crohn's Disease Increases In-Hospital Lengths of Stay, Medical Complications, and Costs of Care following Primary Total Knee Arthroplasty

Bana Hadid
1   Department of Orthopaedic Surgery, Maimonides Medical Center, Brooklyn, New York
2   School of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York
,
Weston Buehring
2   School of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York
,
Angelo Mannino
1   Department of Orthopaedic Surgery, Maimonides Medical Center, Brooklyn, New York
,
Miriam D. Weisberg
1   Department of Orthopaedic Surgery, Maimonides Medical Center, Brooklyn, New York
,
Ivan J Golub
1   Department of Orthopaedic Surgery, Maimonides Medical Center, Brooklyn, New York
,
Mitchell K Ng
1   Department of Orthopaedic Surgery, Maimonides Medical Center, Brooklyn, New York
,
Afshin E. Razi
1   Department of Orthopaedic Surgery, Maimonides Medical Center, Brooklyn, New York
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

The literature has shown an increase in prevalence of Crohn's disease (CD) within the United States alongside a concomitant rise in primary total knee arthroplasty (TKA) procedures. As such, with these parallel increases, orthopaedic surgeons will invariably encounter CD patients requiring TKA. Limited studies exist evaluating the impact of this disease on patients undergoing the procedure; therefore, this study endeavors to determine whether CD patients undergoing primary TKA have higher rates of (1) in-hospital lengths of stay (LOS), (2) medical complications, and (3) episode of care (EOC) costs. To accomplish this, a nationwide database was queried from January 1, 2005 to March 31, 2014 to identify patients undergoing TKA. The study group, patients with CD, was randomly matched to the controls, patients without CD, in a 1:5 ratio after accounting for age, sex, and medical comorbidities associated with CD. Patients consuming corticosteroids were excluded, as they are at risk of higher rates of adverse events following TKA. This query ultimately yielded a total of 96,213 patients, with 16,037 in the study cohort and 80,176 in the control one. The study compared in-hospital (LOS), 90-day medical complications, and day of surgery and total global 90-day EOC costs between CD and non-CD patients undergoing primary TKA. The results found CD patients undergoing primary TKA had significantly longer in-hospital LOS (4- vs. 3 days, p < 0.0001) compared with non-CD patients. CD patients were also found to have significantly higher incidence and odds of 90-day medical complications (25.31 vs. 10.75; odds ratio: 2.05, p < 0.0001) compared with their counterparts. Furthermore, CD patients were found to have significantly higher 90-day EOC costs ($15,401.63 vs. 14,241.15, p < 0.0001) compared with controls. This study demonstrated that, after adjusting for age, sex, and medical comorbidities, patients with CD have prolonged in-hospital LOS, increased medical complications, and higher EOC costs following primary TKA. Therefore, it establishes the importance for orthopaedists to adequately counsel CD patients of the potential complications and outcomes following their procedure.

Keywords

total knee arthroplasty - Crohn's disease - in-hospital lengths of stay - 90-day medical complications - costs of care


Publication History

Received: 03 November 2020

Accepted: 21 September 2021

Article published online:
18 November 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Gajendran M, Loganathan P, Catinella AP, Hashash JG. A comprehensive review and update on Crohn's disease. Dis Mon 2018; 64 (02) 20-57
    CrossrefPubMedGoogle Scholar
  • 2 Ng SC, Shi HY, Hamidi N. et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 2017; 390 (10114): 2769-2778
    CrossrefPubMedGoogle Scholar
  • 3 Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn's disease. Lancet 2017; 389 (10080): 1741-1755
    CrossrefPubMedGoogle Scholar
  • 4 Rothfuss KS, Stange EF, Herrlinger KR. Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol 2006; 12 (30) 4819-4831
    CrossrefPubMedGoogle Scholar
  • 5 Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2015; 21 (08) 1982-1992
    CrossrefPubMedGoogle Scholar
  • 6 Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am 2002; 31 (01) 307-327
    CrossrefPubMedGoogle Scholar
  • 7 Ditisheim S, Fournier N, Juillerat P. et al; Swiss IBD Cohort Study Group. Inflammatory articular disease in patients with inflammatory bowel disease: result of the Swiss IBD cohort study. Inflamm Bowel Dis 2015; 21 (11) 2598-2604
    CrossrefPubMedGoogle Scholar
  • 8 Das KM. Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis. Dig Dis Sci 1999; 44 (01) 1-13
    CrossrefPubMedGoogle Scholar
  • 9 Garber A, Regueiro M. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, etiopathogenesis, and management. Curr Gastroenterol Rep 2019; 21 (07) 31
    CrossrefPubMedGoogle Scholar
  • 10 Satsangi J, Grootscholten C, Holt H, Jewell DP. Clinical patterns of familial inflammatory bowel disease. Gut 1996; 38 (05) 738-741
    CrossrefPubMedGoogle Scholar
  • 11 Kapadia BH, Issa K, Nagrare N, Pivec R, Banerjee S, Mont MA. Higher revision and complication rates following total hip arthroplasty in patients with inflammatory bowel disease. J Arthroplasty 2014; 29 (03) 596-600
    CrossrefPubMedGoogle Scholar
  • 12 Gregory MH, McKinnon A, Stwalley D. et al. Anti-tumour necrosis factor therapy for inflammatory bowel diseases do not impact serious infections after arthroplasty. J Crohn's Colitis 2019; 13 (02) 182-188
    CrossrefPubMedGoogle Scholar
  • 13 Ehrenpreis ED, Zhou Y. Hospital costs, length of stay and prevalence of hip and knee arthroplasty in patients with inflammatory bowel disease. World J Gastroenterol 2017; 23 (26) 4752-4758
    CrossrefPubMedGoogle Scholar
  • 14 Vakharia RM, Ehiorobo JO, Sodhi N, Swiggett SJ, Mont MA, Roche MW. Effects of depressive disorders on patients undergoing primary total knee arthroplasty: a matched-control analysis. J Arthroplasty 2020; 35 (05) 1247-1251
    CrossrefPubMedGoogle Scholar
  • 15 Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis 2009; 15 (07) 1105-1118
    CrossrefPubMedGoogle Scholar
  • 16 Román AL, Muñoz F. Comorbidity in inflammatory bowel disease. World J Gastroenterol 2011; 17 (22) 2723-2733
    CrossrefPubMedGoogle Scholar
  • 17 Long MD, Martin C, Sandler RS, Kappelman MD. Increased risk of pneumonia among patients with inflammatory bowel disease. Am J Gastroenterol 2013; 108 (02) 240-248
    CrossrefPubMedGoogle Scholar
  • 18 Schneeweiss S, Korzenik J, Solomon DH, Canning C, Lee J, Bressler B. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Aliment Pharmacol Ther 2009; 30 (03) 253-264
    CrossrefPubMedGoogle Scholar
  • 19 Lichtenstein GR, Feagan BG, Cohen RD. et al. Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry. Am J Gastroenterol 2012; 107 (09) 1409-1422
    CrossrefPubMedGoogle Scholar
  • 20 Sloan M, Premkumar A, Sheth NP. Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am 2018; 100 (17) 1455-1460
    CrossrefPubMedGoogle Scholar
  • 21 Viola J, Gomez MM, Restrepo C, Maltenfort MG, Parvizi J. Preoperative anemia increases postoperative complications and mortality following total joint arthroplasty. J Arthroplasty 2015; 30 (05) 846-848
    CrossrefPubMedGoogle Scholar
  • 22 Veauthier B, Hornecker JR. Crohn's disease: diagnosis and management. Am Fam Physician 2018; 98 (11) 661-669
    PubMedGoogle Scholar
  • 23 Shimoyama Y, Sawai T, Tatsumi S. et al. Perioperative risk factors for deep vein thrombosis after total hip arthroplasty or total knee arthroplasty. J Clin Anesth 2012; 24 (07) 531-536
    CrossrefPubMedGoogle Scholar
  • 24 López-de-Andrés A, Hernández-Barrera V, Martínez-Huedo MA, Villanueva-Martinez M, Jiménez-Trujillo I, Jiménez-García R. Type 2 diabetes and in-hospital complications after revision of total hip and knee arthroplasty. PLoS One 2017; 12 (08) e0183796
    CrossrefPubMedGoogle Scholar
  • 25 Fryhofer GW, Sloan M, Sheth NP. Hypoalbuminemia remains an independent predictor of complications following total joint arthroplasty. J Orthop 2019; 16 (06) 552-558
    CrossrefPubMedGoogle Scholar
  • 26 Flora GD, Nayak MK. A brief review of cardiovascular diseases, associated risk factors and current treatment regimes. Curr Pharm Des 2019; 25 (38) 4063-4084
    CrossrefPubMedGoogle Scholar
  • 27 Kim CY, Sivasundaram L, LaBelle MW, Trivedi NN, Liu RW, Gillespie RJ. Predicting adverse events, length of stay, and discharge disposition following shoulder arthroplasty: a comparison of the Elixhauser comorbidity measure and Charlson comorbidity index. J Shoulder Elbow Surg 2018; 27 (10) 1748-1755
    CrossrefPubMedGoogle Scholar
  • 28 Ondeck NT, Bovonratwet P, Ibe IK. et al. Discriminative ability for adverse outcomes after surgical management of hip fractures: a comparison of the Charlson comorbidity index, Elixhauser comorbidity measure, and modified frailty index. J Orthop Trauma 2018; 32 (05) 231-237
    CrossrefPubMedGoogle Scholar
  • 29 Ondeck NT, Bohl DD, Bovonratwet P, McLynn RP, Cui JJ, Grauer JN. Discriminative ability of Elixhauser's comorbidity measure is superior to other comorbidity scores for inpatient adverse outcomes after total hip arthroplasty. J Arthroplasty 2018; 33 (01) 250-257
    CrossrefPubMedGoogle Scholar
  • 30 Fernando DT, Berecki-Gisolf J, Newstead S, Ansari Z. Effect of comorbidity on injury outcomes: a review of existing indices. Ann Epidemiol 2019; 36: 5-14
    CrossrefPubMedGoogle Scholar
  • 31 Gologorsky Y, Knightly JJ, Lu Y, Chi JH, Groff MW. Improving discharge data fidelity for use in large administrative databases. Neurosurg Focus 2014; 36 (06) E2
    CrossrefPubMedGoogle Scholar
  • 32 Burles K, Innes G, Senior K, Lang E, McRae A. Limitations of pulmonary embolism ICD-10 codes in emergency department administrative data: let the buyer beware. BMC Med Res Methodol 2017; 17 (01) 89
    CrossrefPubMedGoogle Scholar
  • 33 Yoshihara H, Yoneoka D. Understanding the statistics and limitations of large database analyses. Spine 2014; 39 (16) 1311-1312
    CrossrefPubMedGoogle Scholar
  • 34 Cancienne JM, Brockmeier SF, Carson EW, Werner BC. Risk factors for infection after shoulder arthroscopy in a large Medicare population. Am J Sports Med 2018; 46 (04) 809-814
    CrossrefPubMedGoogle Scholar
  • 35 Medicare. Medicare Fee-for-Service 2012 Improper Payments Report. Accessed October 10, 2021 at: http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-andReports/MedicareMedicaidStatSupp/2012.Centers for Medicare and Medicaid Services. Published: 2012
    PubMedGoogle Scholar
  • 36 Vakharia RM, Naziri Q, Sodhi N, Scuderi GR, Mont MA, Roche MW. Comparison study of patient demographics, risk factors, and lengths of stay for postoperative ileus after primary total knee arthroplasty. J Arthroplasty 2020; 35 (05) 1397-1401
    CrossrefPubMedGoogle Scholar
  • 37 Beard JA, Franco DL, Click BH. The burden of cost in inflammatory bowel disease: a medical economic perspective and the future of value-based care. Curr Gastroenterol Rep 2020; 22 (02) 6
    CrossrefPubMedGoogle Scholar
  • 38 Kappelman MD, Rifas-Shiman SL, Porter CQ. et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology 2008; 135 (06) 1907-1913
    CrossrefPubMedGoogle Scholar
  • 39 Kapadia BH, McElroy MJ, Issa K, Johnson AJ, Bozic KJ, Mont MA. The economic impact of periprosthetic infections following total knee arthroplasty at a specialized tertiary-care center. J Arthroplasty 2014; 29 (05) 929-932
    CrossrefPubMedGoogle Scholar
  • 40 Ruppert A, Steinle T, Lees M. Economic burden of venous thromboembolism: a systematic review. J Med Econ 2011; 14 (01) 65-74
    CrossrefPubMedGoogle Scholar
  • 41 Malcolm TL, Knezevic NN, Zouki CC, Tharian AR. Pulmonary complications after hip and knee arthroplasty in the United States, 2004-2014. Anesth Analg 2020; 130 (04) 917-924
    CrossrefPubMedGoogle Scholar